Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo

Dose Of Pharma Podcasts

show episodes
 
Artwork

1
Dose of Pharma

Dose of Pharma

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
There are a million and one science podcasts out there but none of them are quite like Dose of Pharma! Made for students, by students, we provide you with bite-sized doses of discussions on all sorts of science content, personal development, student life, and STEM careers. With a nugget of wisdom available for you to take away from each episode, you’ll be glad you decided to embrace your inner nerd and start listening to us!
  continue reading
 
Artwork

1
MPR Weekly Dose

MPR Weekly Dose

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly+
 
Each week the MPR team brings you the top stories from the world of medicine and pharma in a matter of minutes. With 35 years of publishing drug information behind us, you can rely on MPR to provide accurate and up-to-date news.
  continue reading
 
Welcome to “A Dose of Reality”, the podcast where we infuse insight, laughter, and practical wisdom into the world of clinical leadership and career development. Hosted by Charles Spence, each episode offers a deep dive into the challenges and triumphs of clinical leadership, providing listeners with meaningful conversations, career insights, and a dose of inspiration to navigate their professional journeys. Whether you're a director, a C-level executive, or a clinical researcher in oncology ...
  continue reading
 
Artwork

1
Pathfinders in Biopharma

RBC Capital Markets

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.
  continue reading
 
THINK aloud is a podcast by ING Global Research hosted by Senior Editor Rebecca Byrne. Subscribe to hear expert analysis on the global economy, monetary policy, and financial markets, that you won't find anywhere else.
  continue reading
 
Artwork

1
SURVIVING HEALTHCARE

Robert Yoho, retired cosmetic surgeon

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Weekly+
 
FOR MORE about surviving healthcare, see robertyohoauthor.com and robertyoho.substack.com. LISTENING HINT: try using 1.5 to 2 x playback speed. I STARTED THIS PODCAST by reading the first half of my two books for you. These are Butchered by “Healthcare” and Hormone Secrets. In return for getting them free, please review them on Amazon! You will find the full audio, ebooks, and paperbacks on Amazon, Audible, Itunes, or many other platforms. I next sponsored guests who help me explain the heal ...
  continue reading
 
Artwork

1
The Dr. Hyman Show

Dr. Mark Hyman

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Weekly+
 
Welcome to The Dr. Hyman Show, the groundbreaking podcast redefining health in America and empowering you to take ownership of your health. Hosted by Dr. Mark Hyman—this show tackles the most pressing issues of our time: chronic disease, mental health, food policy and controversy, prevention and recovery, and longevity. In an era where our food system fuels disease and outdated healthcare models fail to address root causes, Dr. Hyman delivers evidence-based insights and expert interviews to ...
  continue reading
 
Loading …
show series
 
In this episode, I talked with Heidi Wang, CEO of OBI Pharma and Chair of OBIGEN, who shares her powerful story, from losing her father to cancer while raising two children, to leading oncology drug approvals at BMS, and now, building out a bold ADC pipeline in biotech. Heidi opens up about the pressures of leading during personal tragedy, how BMS …
  continue reading
 
On Overdose Awareness Day, we’re joined by our host Jack Cullen and Kamran Zia, a Specialist in Poisons Information at the Victorian Poisons Information Centre, to explore the realities of overdose in Australia. From breaking down common misconceptions to sharing life-saving advice, this conversation shines a light on the importance of awareness, p…
  continue reading
 
For too long, psychiatry has treated mental illness as if it lives only in the brain. But what if the real story begins in the body? My guest today, Dr. Shebani Sethi, is a Clinical Associate Professor at Stanford and founding director of the Metabolic Psychiatry Program, the first clinic to unite psychiatry with nutrition and metabolism.On this re…
  continue reading
 
Many people feel caught in worry, fear, and constant striving—chasing achievements yet never feeling truly fulfilled. The restless “monkey mind” jumps from one thing to the next, amplifying stress and turning setbacks into heavy burdens. It doesn’t have to be that way, though. You can move from mindless tasks to a mindful purpose. The shift begins …
  continue reading
 
New device approved to prevent intrauterine adhesions; oral GLP-1 receptor agonists assessed in head to head trial; nasal spray formulation of bumetanide gains approval; Capvaxive elicits immune response in children aged 2 to 17 years; and a primary biliary cholangitis treatment is withdrawn from the market.…
  continue reading
 
Over the last 18 months, MindMed has undergone an extraordinary transformation. It released compelling data for its LSD-based drug MM120, followed by FDA breakthrough designation for MM120 for the treatment of GAD, and strong financial backing. CEO Rob Barrow outlines the company's ambitious goals and the path to potentially transforming mental hea…
  continue reading
 
Most women are told that midlife decline is inevitable—more aches, weaker bones, less strength. But is that really true?On this episode of The Dr. Hyman Show, I sit down with Dr. Vonda Wright, a double-board certified orthopedic surgeon and leading voice in women’s longevity and performance. She shares how muscle functions as medicine, how hormones…
  continue reading
 
Many psychiatric labels—like bipolar disorder and schizophrenia—can obscure underlying biology, and symptom checklists often fail to explain or heal what’s really going on. Emerging evidence reframes mental illness as a problem of brain energy, mitochondria, and inflammation—shaped by insulin signaling, circadian rhythm disruption, the gut–brain ax…
  continue reading
 
On this episode of The Dr. Hyman Show, I sit down with Nick Brewer, founder of Primal Moves—a method born from his own healing journey. Once a pro skier turned drug smuggler, he spent ten years in prison, including four in solitary, where he discovered the power of breath and movement to rebuild his body and mind.I had the chance to try Nick’s clas…
  continue reading
 
Inflammation is the body’s natural way of healing, but when it becomes chronic and hidden, it quietly drives many of today’s most common health problems—heart disease, diabetes, dementia, cancer, autoimmune conditions, and more. Unlike the redness and swelling from a cut or sprain, this “silent inflammation” often goes unnoticed while slowly damagi…
  continue reading
 
For decades, psychiatry has relied on treatments that are slow and often ineffective. But what if one intervention could reset the brain, break the grip of addiction, and open the door to an entirely new model of care? On this episode of The Dr. Hyman Show, I sit down with Dr. Nolan Williams, a Stanford neuropsychiatrist pioneering new therapies fo…
  continue reading
 
Nutrients are far more than supplements on a shelf—they are life-sustaining molecules that determine how well the body ages and resists disease. For years, their importance was overlooked because many studies were poorly designed, failing to consider existing nutrient levels or how vitamins and minerals work together. Strong evidence now shows mult…
  continue reading
 
It’s been five years since Ben Greenfield joined me on The Dr. Hyman Show, and a lot has changed. Ben isn’t doing many of the things he once swore by. In fact, he’s discovered that some of the most powerful practices for health and longevity are simpler and more sustainable than the extreme routines he became known for. In this episode, we talk abo…
  continue reading
 
As women enter perimenopause and menopause, hormonal shifts—declining estrogen, progesterone, and testosterone—can ripple through nearly every system in the body, impacting bone density, cardiovascular health, metabolism, brain function, and sexual wellbeing. Misinterpretation of past research left millions fearful of hormone therapy, yet newer evi…
  continue reading
 
The American Academy of Pediatrics release their own immunization schedule; The American Heart Association update 2017 guidelines for the prevention of high blood pressure; weight loss drug gains indication to treat noncirrhotic MASH; FDA approve a new fibromyalgia treatment; investigational SCD Tx to meet trial endpoint.…
  continue reading
 
In this episode of Dose of Pharma, we were joined by two inspiring guests: Ella Shearing, a hospital pharmacist specialising in ortheopedics and clinical trials and a marketing associate at Locumate.ai, and Chantelle Florenca, a community pharmacist and Head of Social Impact at Locumate.ai. We explored the importance of sustainability for the futur…
  continue reading
 
In a world where healthcare often focuses on treating illness rather than promoting wellness, what does it really take to live a healthy, vibrant life?In this episode of The Dr. Hyman Show, I sit down with John Mackey, co-founder of Whole Foods Market, to explore his journey from building one of America’s most iconic food companies to rethinking he…
  continue reading
 
Relationships have the power to change lives in ways both visible and hidden. Deep, supportive bonds can quiet inflammation in the body, protect against disease, and anchor people through decades of triumphs and trials. Communities that come together—whether in small groups at a church or around a shared health goal—often achieve far more than indi…
  continue reading
 
What does life look like after a PhD? Join host Jack Cullen as three powerhouse guests- Dr. Emma Xu, Dr. Aaron Debono, and Dr. Madeline Nicholson, share how they pivoted from academia to exciting roles in pharma, business, and biotech. Packed with career tips, honest stories, and industry insights, this episode is your guide to turning academic roo…
  continue reading
 
Nerve stimulation device cleared for sleep apnea; Skysona safety update; new non-cystic fibrosis bronchiectasis treatment; FDA cracks down on animal-derived thyroid meds; RSV therapy to be discontinued.
  continue reading
 
In this episode, I talked with Dr. András Strassz, Chief Medical Officer at Heidelberg Pharma, to hear about his two decades of leadership in oncology drug development—and the often-overlooked realities behind building teams, designing clinical trials, and making biotech work. András opens up about key moments in his career, including the personal …
  continue reading
 
With so much conflicting health advice online, it’s no wonder people feel overwhelmed by food choices. Is saturated fat really the enemy? Are seed oils as harmful as some headlines claim? And how do we know what’s actually true? In this episode of The Dr. Hyman Show, I sit down with nutrition researcher and author Simon Hill to make sense of the la…
  continue reading
 
Medicine stands at the threshold of a new era, where artificial intelligence and systems biology are working hand in hand to make care more personal, predictive, and precise than ever before. AI is already improving diagnostic accuracy, automating administrative tasks, and uncovering patterns in data—like retinal scans or genomics—that humans often…
  continue reading
 
This special bonus episode features Dr. Todd LePine from the UltraWellness Center, diving into how functional medicine can help reverse fatty liver disease—an often-overlooked condition that’s quietly affecting millions. While conventional care may miss early warning signs or focus solely on medication, Dr. LePine and I take a deeper look at the ro…
  continue reading
 
Class-wide label change for opioids; positive results for oral GLP-1; migraine prevention therapy approved for children; FDA removes restriction on Ixchiq for older adults; Modeyso approved for rare brain tumor.
  continue reading
 
Our healthcare system is broken—and it’s not by accident. On this episode of The Dr. Hyman Show, I’m joined by Brigham Buhler, a former pharmaceutical rep turned healthcare entrepreneur, to explore how misaligned incentives across pharma, insurance, and government are undermining patient care. This conversation is about more than just exposing the …
  continue reading
 
The Trump administration has imposed a 15% tariff on EU pharmaceuticals and threatened even steeper levies elsewhere. At the same time, however, the government has issued ultimatums to 17 companies to cut drug costs. In this podcast, ING's Diederik Stadig explains why these competing goals cannot be reconciled, and what the strategy means for the i…
  continue reading
 
In this episode, I talked with Dr. Steven Katz, CMO and SVP of Translational Science for Shinobi Therapeutics, a biotech company pioneering off-the-shelf immune-evasive IPSC-derived cell therapies, and Professor of Surgery at Brown University. We get into why technical skills alone won’t cut it—and how the wrong hire, even if they look great on pap…
  continue reading
 
Social media platforms are designed to hijack our brain’s reward system, keeping us hooked through endless dopamine hits. This constant stimulation fragments our attention, reshapes our behavior, and can lead to burnout, anxiety, and even addiction—especially in developing brains. The more we scroll, the more we crave quick hits of novelty, making …
  continue reading
 
Empaveli approved to treat two rare kidney diseases; Elevidys available again for ambulatory patients; Mounjaro shows benefit in cardiovascular disease; wearable cardiac monitor gets clearance; upadacitinib trial shows hair regrowth in individuals with alopecia areata.
  continue reading
 
On this episode of The Dr. Hyman Show, we’re exploring the emerging science of metabolic psychiatry. My guest, Dr. Iain Campbell, is a researcher at the University of Edinburgh and someone who has lived with bipolar disorder himself. He brings a rare dual perspective as both a scientist and a patient to this critical conversation. Together, we disc…
  continue reading
 
In this episode, I talked with Christian Mueller, Chief Development Officer at Immutep. Christian’s path into biotech wasn’t exactly planned—from summarizing VC business plans during his studies to becoming a driving force behind the world’s first Claudin 18.2-directed antibody. We talked about the wins and the setbacks: from finally securing Pembr…
  continue reading
 
ADHD and other brain-based conditions such as depression, autism, and even schizophrenia are increasingly understood as inflammatory disorders of the brain—deeply rooted in the complex interplay between genetics, environment, and lifestyle. Many individuals go undiagnosed for years, internalizing harmful labels like “lazy” or “difficult,” until the…
  continue reading
 
Elevidys shipments paused following third death; FDA committee votes against brexpiprazole combo for PTSD; Rapiblyk now available for SVT; sleep apnea pill looks promising; JUUL e-cigarettes gain marketing authorization.
  continue reading
 
Paris Panayiotopoulos, Senior Managing Director at Blackstone Life Sciences, shares how the firm’s broad life sciences strategy has been advancing innovation across the life sciences ecosystem in three key ways: late-stage product financing (Collaboration) and new company creation (Ownership), and non-dilutive financing (Credit and Royalties). He e…
  continue reading
 
A year ago, James told me he doubted whether he was having much of an impact, but now the WHO is losing influence. Repealing the PREP Act before the midterm elections is his new priority. Support the showBy Robert Yoho, retired cosmetic surgeon
  continue reading
 
Loading …
Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play